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Nanotechnologies are emerging platforms that could be useful in measuring, understanding, and manipulat-
ing stem cells. Examples include magnetic nanoparticles and quantum dots for stem cell labeling and in vivo
tracking; nanoparticles, carbon nanotubes, and polyplexes for the intracellular delivery of genes/oligonucle-
otides and protein/peptides; and engineered nanometer-scale scaffolds for stem cell differentiation and
transplantation. This review examines the use of nanotechnologies for stem cell tracking, differentiation,
and transplantation. We further discuss their utility and the potential concerns regarding their cytotoxicity.The wide spectrum of nanotechnologies (referred to as nano-
medicine by the National Institutes of Health for applications in
the biomedical area) holds great promise for the study of stem
cell biology and the development of new approaches to stem cell
expansion, differentiation, and transplantation (Chen et al., 2007;
Silva et al., 2004; Sniadecki et al., 2006). The term ‘‘nanotechnol-
ogies’’ in the title of this article reflects nanoscale (on the scale of
approximately 1–1000 nm) or nanostructured materials used for
medical diagnosis, drug delivery, and implants, which require
novel and demanding chemical and manufacturing techniques.
Therefore, the concept implies either the improvement of current
materials or the advent of new materials with modified funda-
mental properties and bioactivity.
Examples of nanotechnologies in stem cell research are
organic and inorganic nanoparticles (Corsi et al., 2003; Huang
et al., 2005; Kutsuzawa et al., 2008), quantum dots (Chen
et al., 2007; Shah et al., 2007; Slotkin et al., 2007), carbon nano-
tubes (Zhu et al., 2007), nanofibers (Dang and Leong, 2007; Silva
et al., 2004; Yang et al., 2005), and nanoscale-engineered sub-
strates (Bettinger et al., 2008; Dalby et al., 2007; Derda et al.,
2007; Jan and Kotov, 2007) (Figure 1). Potential applications of
nanotechnologies in stem cell research include (1) tracking of
stem cell surface molecules and detailed examination of molec-
ular motion without photobleaching, (2) noninvasive tracking of
stem cells and progenitor cells transplanted in vivo, (3) stem
cell delivery systems that enhance the survival of transplanted
cells by releasing prosurvival biomolecules, (4) nanopatterned
substrates that present covalently tethered biologically active
molecules (adhesion sites, growth factors, and synthetic pep-
tides) for stem cell differentiation and transplantation, and (5) in-
tracellular delivery of DNA, RNAi, proteins, peptides, and small
drugs for stem cell differentiation (Moghimi et al., 2005; Muschler
et al., 2004). Though nanotechnologies are very powerful with
respect to micro- and macroenvironmental control, they may
have harmful drawbacks. Systematic studies must assess their
toxicological profiles and evaluate potential interference with
the self-renewal and differentiation programs of stem cells.
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Although some of the nanotechnologies described herein have
already been applied to cell biology, their use in stem cell biology
and regenerative medicine is more recent. This is likely due to (1)
advances in the preparation of safer and more effective nanoma-
terials for biomedical applications, (2) growing awareness of
material science and tissue engineering researchers regarding
the potential of stem cells for regenerative medicine, (3) notable
success in the application of nanotechnologies to medicine, and
(4) developments in stem cell biology and the isolation of novel
sources of stem cells.
Recent developments in the use of nanotechnologies with
stem cells have been motivated by the continuous introduction
of novel nanotechnology platforms during the last few years.
Some of the nanomaterials reviewed here were discovered in
the 1990s through technological developments such as carbon
nanotubes, quantum dots, and nanowires. In some cases, the
use of nanotechnologies in the stem cell field was propelled by
research performed initially on somatic cells. For example, al-
though the use of quantum dots for cell labeling was described
in 1998 (Bruchez et al., 1998; Chan and Nie, 1998), their use
for labeling stem cells is recent (Hsieh et al., 2006b; Seleverstov
et al., 2006). Similarly, though the use of magnetic nanoparticles
for intracellular labeling and detection by MRI was reported in the
early 1990s (Yeh et al., 1993), only in 2000 were they applied to
stem and progenitor cells (Lewin et al., 2000). In other cases,
some established nanotechnologies were only recently used in
the biomedical arena. The first patent in the preparation of elec-
trospun nanofibers was awarded in 1934; however, they re-
ceived little interest from biomedical researchers until the mid
1990s (Dzenis, 2004), and only in the 21st century were nano-
scaffolds prepared for the culture and transplantation of stem
cells (Li et al., 2005).
As necessity is often considered the mother of invention, new
techniques are adapted when the need is recognized as a general
problem. For example, as exogenous cell therapy undergoes
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Stem Cell Research
(A) Nanomaterials for stem cell labeling and track-
ing in vivo. Stem cells labeled by superparamag-
netic iron oxide nanoparticles or fluorescent quan-
tum dots might be tracked by magnetic resonance
imaging or cell imaging systems, respectively,
either in vitro or in vivo. In most cases, stem cells
are loaded with nanomaterials at concentrations
that do not exert cytotoxic effects.
(B) Many powerful strategies for the differentiation
of stem cells require the delivery of bioactive
molecules (e.g., plasmid DNA, siRNA, proteins,
peptides, and small molecules) into the cytosolic
or nuclear compartments of these cells. Polymeric
nanocarriers, carbon nanotubes, and polyplexes
are examples of nanomaterials used to deliver
biomolecules within stem cells. In the case of poly-
meric nanocarriers and polyplexes, the material
might degrade over time within the cell.
(C) Nanoscale-engineered substrates and scaf-
folds to create biomimetic cellular environments.
Stem cell adhesion to substrates or scaffolds
with nanoscale resolution can cause clustering of
cell integrins into focal adhesion complexes, and
the concomitant activation of intracellular signal-
ing cascades and guidance of stem cell behavior.rigorous testing in animal and human trials, it has become
increasingly important to track the movement of transplanted
cells to assess toxicity and therapeutic efficacy.
Nanomaterials for Stem Cell Labeling
and Tracking In Vivo
Magnetic Nanoparticles
The history and fate of transplanted stem cells or progenitor cells
is generally assessed by labeling them in vitro with a fluorescent
dye, thymidine analog (e.g., BrdU), or a transfected gene such as
LacZ or green fluorescent protein (GFP) and visualization by
immunohistochemistry after the removal of tissues or organs.
One of the main goals in stem cell research is long-term noninva-
sive imaging of transplanted cells in vivo to monitor their survival,
migration, differentiation, and regenerative impact. Magnetic
resonance imaging (MRI) provides a noninvasive, in vivo method
for studying the fate of transplanted cells labeled with magnetic
nanoparticles. MRI offers several advantages over other tech-
niques such as positron emission tomography including greater
speed, higher spatial resolution, more direct anatomical correla-
tion, and lower cost (Stroh et al., 2005). In vivo images with a
spatial resolution of 50 3 50 3 500 mm can be acquired over
2 to 3 hr (Allport and Weissleder, 2001).
Superparamagnetic iron oxide (SPIO) nanoparticles have been
used as a feasible means to enhance the contrast of cellular
targets in MRI. Among several types of nanoparticles described,
some (e.g., Feridex/Endorem and Ferucarbotran) have been ap-
proved for human use by the U.S. Food and Drug Administration
(FDA) as MRI contrast agents (Reimer and Balzer, 2003; Wang
et al., 2001) (Table S1 available online). Generally, a SPIO nano-
particle is composed of an iron oxide core coated with dextran
(ferumoxides, commercialized by Guerbert and Berlex Laborato-
ries under the trademarks Endorem and Feridex, respectively) or
carboxydextran (Ferucarbotran, commercialized by Schering)
that ensures aqueous solubility and prevents nanoparticle aggre-
gation (Reimer and Balzer, 2003; Wang et al., 2001). The iron
oxide core is normally formed by magnetite Fe3O4. The overallhydrodynamic diameters of Ferucarbotran and Feridex/Endorem
are 80–150 nm and 62 nm, respectively (Wang et al., 2001).
Most labeling techniques currently use one of two ap-
proaches: (1) attaching magnetic nanoparticles to the stem cell
surface or (2) internalizing biocompatible magnetic nanoparticles
by endocytosis or phagocytosis. Surface labeling has some lim-
itations, including iron content that is generally lower by an order
of magnitude than intracellular labeling procedures using SPIO
nanoparticles (Sykova and Jendelova, 2005). In addition, al-
though surface labeling is efficient for in vitro cell separation, it
is generally unsuitable for in vivo use because of rapid reticuloen-
dothelial recognition and clearance of labeled cells (Lewin et al.,
2000). For in vivo tracking using magnetic resonance cell imag-
ing, SPIO nanoparticles are generally taken up through stem
cell endocytosis during in vitro cultivation (Figure 2). Human
mesenchymal stem cells (hMSCs) internalize SPIO nanoparticles
in the absence of transfection agents at a concentration up to
23.4 pg Fe/cell (Hsiao et al., 2007). However, in most cases, in-
ternalization of SPIO nanoparticles requires the use of excipient
(Table S1). For example, for improved cellular magnetic labeling,
nanoparticles have been derivatized with a short HIV-1 trans-
activating transcriptional activator (TAT) peptide (Lewin et al.,
2000), which mediates nanoparticle internalization by membrane
receptor binding or by coating iron oxide nanoparticles with
dendrimers (Bulte et al., 2001). Others have used protamine
sulfate, a small cationic transfection agent approved by the
FDA within certain products, to facilitate the uptake of SPIO
nanoparticles into stem cells (Arbab et al., 2004). The average
iron content per cell after labeling varied from 1.47 pg to 17.90
pg Fe, depending on the incubation time, cell type, and cell
culture methodology used (Arbab et al., 2004).
A number of factors affect the MRI detection threshold of
SPIO-labeled cells, such as the SPIO concentration per cell,
and intrinsic MRI parameters, such as field strength, signal-to-
noise ratio, pulse sequence, and acquisition parameters (Guz-
man et al., 2007; Heyn et al., 2005). Some studies have shown
that as little as 1.4–3.0 pg of iron per cell is sufficient for detectionCell Stem Cell 3, August 7, 2008 ª2008 Elsevier Inc. 137
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has been described (Hoehn et al., 2002); however, in most cases
MRI detection requires clusters of thousands of labeled cells
(Guzman et al., 2007).
SPIO-labeled stem cells/progenitor cells might contribute to
our understanding of cell migration processes in the context of
numerous diseases, such as neurologic diseases (Guzman
et al., 2007), myocardial infarction (Arai et al., 2006; Kraitchman
et al., 2005), and cancer (Arbab et al., 2006). For example, mag-
netically labeled mouse embryonic stem cells (mESCs), injected
into the nonischemic side of the brain of a rat with partial brain
ischemia, migrate along the corpus callosum, populating the
border zone of the ischemic area of the contralateral hemisphere
(Hoehn et al., 2002). In addition, the use of SPIO-labeled stem
cells in animal models of disease can help determine optimal
timing and location of transplantation. A recent study has dem-
onstrated that human central nervous system stem cells that
are transplanted into a mature rodent brain migrate only after ce-
rebral injury (cerebral stroke) (Guzman et al., 2007). In this case,
stem cells transplanted into the cortical region of the brain
migrate through an ipsilateral transcortical migration pathway;
the extent of transcortical migration depends upon the distance
between the graft site and the lesion. In addition to the informa-
tion obtained from cell migration studies, SPIO technology might
yield important information about the differentiation process of
stem cells/progenitor cells. SPIO-labeled CD34+ progenitor cells
injected into rodents can be isolated by magnetic separation
after in vivo migration to study the differentiation of these cells
exposed to a biological environment (Lewin et al., 2000).
A clinical study using stem cells labeled with SPIO in patients
with neurological disease has recently been reported (Zhu et al.,
2006). This approach can be adapted to evaluate the therapeutic
effects of stem cells in the context of other diseases, including
myocardial infarction. SPIO nanoparticles have not been yet ap-
proved by the FDA specifically as intracellular contrast agents.
The unclear framework for approving new nanomaterials as
Figure 2. Strategies to Deliver
Nanomaterials within Stem Cells
Schematic representation of steps involved in
cytosolic and nuclear delivery of nanomaterials
into stem cells. Nanomaterials can enter the
stem cell either by (i) receptor-mediated interac-
tions or (ii) nonspecific internalization pathways.
In both cases, the nanomaterials become entrap-
ped within endosomes and are then released in
the cytoplasm or trafficked to the acidic environ-
ments of lysosomes for degradation. Cytoplasm-
released nanomaterials might then be transported
to the nucleus of the cell.
medical products (Helmus, 2007) might
delay the clinical use of SPIO nanopar-
ticles.
In clinical trials involving bone marrow-
derived stem cells and hematopoietic
stem cells that are used in patients within
24 hr after their isolation, the labeling of
stem cells with SPIO nanoparticles
should be performed in less than one
day. A rapid method to label stem cells
has recently been reported based in the electroporation of cells
(‘‘magnetoelectroporation’’) (Walczak et al., 2005). This tech-
nique involves low-voltage pulses to induce endocytosis of con-
trast agents in a matter of minutes. In addition to the advantage
of rapid labeling of cells, this technique does not require trans-
fection agents for the internalization of SPIO nanoparticles,
which simplifies the regulatory pathway required for approval
by regulatory agencies.
Despite the unique ability of MRI to track SPIO-labeled stem
cells after their in vivo transplantation, this technique has some
limitations. First, long-term observation of SPIO-labeled stem
cells might be limited because of dilution of SPIO by cell division.
For example, the initial SPIO concentration in neural stem cells
(NSCs) was shown to decrease by 50% every 3 days in vitro
(Guzman et al., 2007). Nonetheless, neural stem cells were
tracked in vivo for up to 18 weeks (Guzman et al., 2007). Second,
due to the in vivo migration of SPIO-labeled stem cells, the
density of cells is reduced considerably over time, leading to
a gradual loss of MRI cell signal (Guzman et al., 2007). Third, it
is important to note that MRI cannot determine whether the
SPIO-labeled stem/progenitor cells differentiate into a specific
cell type, but cell function may be inferred from complementary
imaging studies, such as positron emission tomography or opti-
cal imaging (Arbab et al., 2006). Fourth, in most cases, MRI stud-
ies are conducted with a 1.5 T MRI unit, which has limited spatial
resolution. Improvement in spatial resolution requires stronger
magnetic fields; however, the potential hazards of these mag-
netic fields are still unknown (Hsiao et al., 2007; Stroh et al.,
2005). Fifth, SPIO nanoparticles are not detected directly, but
indirectly through microscopic disturbances of the magnetic
field that misalign the orientation of water protons from which
the magnetic resonance signal is derived (Bulte, 2005). There-
fore, it is difficult to correlate the magnetic resonance signal to
the number of cells. However, perfluoropolyether nanoparticles,
which can be detected directly by 19F imaging, offer an alterna-
tive to SPIO nanoparticles for accurate counting of local cells
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cytotoxicity of these nanoparticles after internalization by stem
cells (Bulte, 2005).
Cytotoxicity of Magnetic Nanoparticles
SPIO nanoparticles are composed of biodegradable iron that
might be reused/recycled by cells using biochemical pathways
for iron metabolism. Potential mechanisms of iron-mediated
toxicity include generation of iron-catalyzed reactive oxygen
species (Hoepken et al., 2004). The cytotoxicity of SPIO nanopar-
ticles has been evaluated in hMSCs (Hsiao et al., 2007; Lu et al.,
2007), mESCs (Arai et al., 2006; Stroh et al., 2005; Sykova and
Jendelova, 2005), and NSCs (Bulte et al., 2001; Guzman et al.,
2007; Wang et al., 2006). In most cases, the internalization of
these nanoparticles by stem cells did not affect cell viability,
growth, or differentiation. So far, only one study has demon-
strated that the internalization of SPIO nanoparticles impaired
the differentiation of stem cells. Bulte et al. reported that the
uptake of SPIO by hMSCs (intracellular iron incorporation of
13–16 pg Fe/cell), in the presence of the transfection agent
poly-L-lysine, impaired their chondrogenic differentiation (Bulte
et al., 2004). Although the results of this study suggest that the
inhibition effect was mediated by the Fe itself and not the trans-
fection agent (Bulte et al., 2004), a study carried out by Arbab
et al. suggests that impairment was caused by the transfection
agent and not the Fe (Bulte et al., 2004). Subsequent studies con-
firmed that the internalization of SPIO nanoparticles by hMSCs
using a liposome transfection agent did not affect their chondro-
genic, adipogenic, or osteogenic differentiation (Song and Ku,
2007).
When choosing appropriate tracking agents, it is important to
consider their respective imaging requirements. Use of magnetic
nanoparticles often requires complex imaging systems, such as
MRI, whereas use of quantum dots relies on optical imaging,
which may be more accessible to the majority of researchers.
Quantum Dots
Quantum dots (qdots) are another class of nanomaterials used for
the long-term labeling of stem cells and monitoring fate and
regenerative potential. Qdots are light-emitting nanocrystals,
typically in the size range of 2–10 nm, composed of atoms from
groups II–VI (e.g., CdSc, CdTe, CdS, and ZnSe) or III–V (e.g.,
InP and InAs) of the periodic table. Since the first studies in
1998 reporting the use of colloidal qdots for cell labeling, many re-
searchers have used them in biolabeling (Bruchez et al., 1998;
Chan and Nie, 1998). Colloidal qdots with a wide range of biocon-
jugation are now available commercially. Qdots are superior to
organic dyes or fluorescent proteins for long-term cell labeling
because of their photostability and durable fluorescence intensity
(up to a few hours using confocal microscopy) (Alivisatos, 2004;
Michalet et al., 2005). The long fluorescence lifetime of qdots
allows their signal to be separated from background autofluores-
cence in cells or tissues. In addition, the narrow emission spec-
trum and broad excitation spectrum of qdots allow simultaneous
analysis of multiple cell targets using a single wavelength activa-
tion (Alivisatos, 2004; Michalet et al., 2005).
One of the potential applications of these nanomaterials is to
follow the dynamics of cellular components in real time. For ex-
ample, qdots have been used to study the membrane diffusion of
integrins during the differentiation of bone marrow-derived pro-
genitor cells (BMPC) (Chen et al., 2007). A similar approach couldbe adopted to study the participation and clustering of multiple
integrins involved in the differentiation of stem cells and progen-
itor cells over time, either ex vivo or in vivo. Since integrins are
crucial for transmitting many extracellular signals to stem cells,
their study could lead to the design of more effective tissue-
engineered scaffolds for stem cell transplantation.
Another advantageous application of qdots is for immunolab-
eling of proteins in sections of tissue with inherent autofluores-
cence such as the heart (Rota et al., 2007), which can lead to
misleading artifacts during conventional immunostaining. After
heart injury, autofluorescence increases due to accumulated
lipofuscin, blood-derived pigments and other fluor-based mole-
cules (Laflamme and Murry, 2005). The photostability of qdots
allows preservation of the fluorescence signal of the stained
biomolecule over time while eliminating the autofluorescence.
Qdots are also attractive nanomaterials for monitoring stem
cell survival, location, and differentiation either in vitro or
in vivo due to their inherent long-term fluorescence intensity
(Chakraborty et al., 2007; Lei et al., 2008; Lin et al., 2007; Shah
et al., 2007; Slotkin et al., 2007). Stem cells are exposed to qdots
suspended in culture media, followed by their cellular internaliza-
tion and quantification of fluorescence signal by cell imaging
systems. In most cases, efficient internalization of qdots requires
the use of specific peptides such as cholera toxin (Chakraborty
et al., 2007), TAT-peptide (Lei et al., 2008), RGD (Shah et al.,
2007), or phospholipids (Slotkin et al., 2007) (Figure 2). mESCs
labeled with qdots with a high extinction coefficient and wide
emission spectra within the near-infrared region (800 nm) could
be detected in animals up to 14 days postinjection using an op-
tical imaging system (Lin et al., 2007). However, qdots were not
detected in animals 28 days postinjection, likely due to dilution
and diffusion.
Qdots’ long-term fluorescence make them an important new
class of nanomaterials available for advancing the stem cell field.
Although qdots can be optically imaged, in vivo tracking typically
requires access to whole animal imaging, which may limit prog-
ress in this area. Whole animal imaging systems such as Cali-
per’s IVIS have been widely used for imaging stem cells in vivo
(Cao et al., 2006; Duan et al., 2007), yet none of these studies
have so far have employed qdot labeling as a tool to track
stem cells in vivo. Given the significantly higher quantum yield
with qdot labeling and minimal autofluorescence at near infrared
fluorescence wavelengths, it is anticipated that a qdot approach
would dramatically enhance the sensitivity and even reduce
detection thresholds. It is expected that in the short term, qdots
will be used primarily as in vitro tools, since MRI and SPIO nano-
particle technology has a longer track record for imaging stem
cells in vivo. There are also concerns over the toxicity of qdots,
as outlined below.
Cytotoxicity of Qdots
The effects of qdots on stem cell self-renewal and differentiation
are largely unknown, particularly in embryonic stem cells. Some
studies have reported no adverse effects on stem cell morphol-
ogy, viability, proliferation, or differentiation over the duration of
the experiments (from several hours to several days) at qdot
concentrations optimized for labeling efficiency (Chakraborty
et al., 2007; Shah et al., 2007); while others have noticed alter-
ations in the differentiation profile of stem cells (Hsieh et al.,
2006a, 2006b) and abnormalities during embryo development
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nocuous, but there is likely to be a safe range within which
they can accomplish their task without major interference in
the processes under study (Michalet et al., 2005).
Perhaps the broadest effort to study the cytotoxicity of qdots
in stem cells has been made using hMSCs. Some studies have
reported that qdots do not affect cellular proliferation or cell-
cycle distribution but do affect chondrogenic and osteogenic
differentiation potential (Hsieh et al., 2006a, 2006b). However,
recent findings indicate that qdots do not interfere with the differ-
entiation program of stem cells (Chakraborty et al., 2007; Shah
et al., 2007). hMSCs labeled with a range of external doses of
qdots conjugated with a cell-penetrating peptide (cholera toxin)
from 250 pM to 16 nM maintained their osteogenic differentiation
potential. The cells showed upregulation of alkaline phosphatase
activity, an early osteogenic marker, when cultured in osteogenic
media and expressed the osteogenic gene Osterix after expo-
sure to BMP-2 (Chakraborty et al., 2007). In a another study,
hMSCs labeled with an exogenous concentration of 30 nM qdots
were viable and continued to proliferate for at least 22 days while
retaining qdots in their cytoplasm (Shah et al., 2007). No interfer-
ence of qdots was detected in the differentiation of hMSCs into
osteogenic, chondrogenic, and adipogenic cell lineages.
The conflicting results of these studies might be related to
different sources of qdots (inherent chemical composition [Der-
fus et al., 2004], size [Lovric et al., 2005a], and surface coating
[Derfus et al., 2004]), mode of qdot internalization, and intrinsic
characteristics of the target cells used. In most studies, the cyto-
toxicity of qdots is based on extracellular nanoparticle exposure
concentrations; however, qdot size and surface coating might
affect their cellular internalization and, consequently, their intra-
cellular concentration. This variability presents a significant chal-
lenge to performing comparative studies of mechanisms of utility
or toxicity. A recent study demonstrated the relevance of intra-
cellular levels of qdots (Chang et al., 2006). The study correlated
cellular toxicity with the intracellular exposure of modified qdots
with a variety of surfaces and demonstrated that biocompatibility
of surface coatings improves as cellular uptake of qdots via
endocytosis decreases (Chang et al., 2006). Moreover, the cyto-
toxicity of qdots might arise from their intracellular degradation.
Qdots are generally taken up by cellular endocytosis into vesi-
cles called endosomes. (Figure 2) These endosomes are then
trafficked to various cellular compartments, in particular the peri-
nuclear region (Hsieh et al., 2006a; Seleverstov et al., 2006). The
accumulation of qdots in cell nuclei has been reported (Dubertret
et al., 2002); however, this process depends on the cell type and
the surface coating of qdots (Shah et al., 2007). Nanomaterials
that cannot be used by the cell are trafficked to acidic and oxida-
tive environments of lysosomes and peroxisomes for degrada-
tion. (Figure 2) The oxidative degradation of qdots releases
Cd2+ (Derfus et al., 2004), which can bind to the sulfhydryl groups
of critical mitochondria proteins, leading to mitochondria dys-
function and, ultimately, cell poisoning (Rikans and Yamano,
2000). The release of reactive oxygen species during the degra-
dation of qdots also contributes to cytotoxicity (Lovric et al.,
2005a; Lovric et al., 2005b).
In addition to the need for tracking stem cells, there is a great
need to exercise control over cell function, which can also be
addressed with nanotechnologies.
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Intracellular Delivery of Genetic Material
with Nanomaterials
Gene delivery [DNA or RNA interference (RNAi)] can be a power-
ful strategy to study the basic biology of stem cells or to direct
their differentiation into specific cell types (Hough et al., 2006;
Meinel et al., 2006). Genes can be delivered by viral and nonviral
vectors. Viral vectors including retroviruses, lentiviruses, and
adenoviruses have been extensively used for cellular transfec-
tion because of their efficient gene delivery and durable gene ex-
pression (Clements et al., 2006; Gropp and Reubinoff, 2006).
However, these viral carriers have a number of disadvantages,
including risk of toxicity, immunogenicity, insertional mutagene-
sis, and high manufacturing costs (Glover et al., 2005; Pack et al.,
2005). In contrast, nonviral vectors, such as polymers (Clements
et al., 2007; Corsi et al., 2003; Incani et al., 2007), lipids (Clem-
ents et al., 2007), and physical delivery methods such as electro-
poration (Zwaka and Thomson, 2003) and nucleofection (Aluigi
et al., 2006; Lakshmipathy et al., 2004) offer several advantages
over viral vectors, including high gene-carrying capacity, low risk
of immunogenicity, as well as low cost and ease of production
(Glover et al., 2005). In the case of nonviral vectors, most efforts
are focused on the development of polymeric approaches for
gene delivery, mainly due to low cost, ease of production, and
controllable toxicity based on parameters including ionic charge,
chemistry, and chain length.
Polymers are typically cationic and interact electrostatically
with negatively charged DNA/RNA molecules, condense the
genetic material into particles to several hundred nanometers
in diameter, protect the genes from enzymes, and mediate cellu-
lar entry. Complexes of plasmid DNA with cationic polymers are
known as polyplexes (Pack et al., 2005). Polymers that have
been used for stem cell transfection include poly(L-lysine)-pal-
mitic acid (Clements et al., 2007), chitosan (Corsi et al., 2003),
polyethylenimine (Incani et al., 2007) (PEI), and poly(L-lysine)
(Incani et al., 2007). For example, a polyplex formed by plasmid
DNA and poly(L-lysine)-palmitic acid transiently transfected
embryonic stem cells with a maximum efficiency of 22%. This
method was significantly more effective than lipofectamine TM
2000-mediated transfection (liposome-based delivery system),
which achieved 11% transduction under optimal conditions
(Clements et al., 2007). These polyplexes have transfection
efficiency equivalent to that of adenoviral vectors (35% after
24 hr) for the delivery of plasmid DNA in bone marrow stromal
cells (Incani et al., 2007).
Nanoparticles have also been used for gene transfection. For
example, apatite nanoparticles coated electrostatically with
fibronectin and E-cadherin have been reported to be efficient
gene delivery systems for embryonic stem cells (Kutsuzawa
et al., 2006). Specific binding to cell surface integrin and E-cad-
herin molecules through double-ligand-created nanoparticles
resulted in synergistic acceleration of gene delivery and subse-
quent expression into embryonic stem cells (59% of the cells
expressed the gene) (Kutsuzawa et al., 2006, 2008). Gene ex-
pression was almost three times higher for this system than
that typical of commercially available lipofectamine TM 2000.
Genetic material can be delivered within stem cells using a
nanoscale-engineered cell substratum (Kim et al., 2007). Gene
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wire arrays, although at low levels (1%). The ability of the arrays
to penetrate the living cells did not impair cell viability when the
diameter of the nanowires was relatively small compared with
the diameter of the cells.
Another promising strategy for cell transfection is the use of
carbon nanotubes. Nanotubes incorporating different functional
groups are transported toward the perinuclear region a few
hours after initial contact with cells, even under endocytosis-
inhibiting conditions (Kostarelos et al., 2007). Although these
nanomaterials have been used as delivery systems for nucleic
acids, proteins, and drug molecules into mammalian cells
(Bianco et al., 2005), their use in stem cells has not been signif-
icantly explored. Initial studies have focused on the cytotoxicity
of these nanomaterials, and more research is needed to further
evaluate their potential as biomolecule delivery vectors.
Intracellular Delivery of Peptide- or Protein-Based
Molecules with Nanomaterials
Intracellular delivery of biomolecules, including proteins, growth
factors, and small chemicals, is powerful method by which to
control the differentiation of stem cells. We recently reported
a new approach for the delivery of vascular growth factors into
hESCs by incorporating growth factor-release particles into em-
bryoid bodies (EBs) (Ferreira et al., 2008). We demonstrated that
the incorporation of these polymeric biodegradable particles has
a minimal effect on cell viability and proliferation but a great
impact on differentiation. In some cases, the effect on vascular
differentiation of incorporation of particles containing growth
factors was superior to that produced by exposing EBs to large
extrinsic doses of the same growth factors. In addition, we stud-
ied the intracellular trafficking of particles of different sizes within
hESCs. We demonstrated that nanoparticles (diameter240 nm)
could be taken up by hESCs and accumulate in the perinuclear
region (Ferreira et al., 2008). These nanoparticles could serve
as a platform to deliver growth factors and other biomolecules
within stem cells. However, it will be crucial to ensure cytocom-
patibility of each formulation, likely on a case-by-case basis.
Cytotoxicity of Nanomaterials Used for Intracellular
Drug Delivery
The cytotoxicity of polyplexes and nanoparticles has been eval-
uated in mESCs (Tran et al., 2007), hESCs (Ferreira et al., 2008),
hMSCs (Corsi et al., 2003), and rat bone marrow stromal cells
(Incani et al., 2007). In general, the cytotoxicity profile correlates
with nanoparticle chemistry (Corsi et al., 2003; Incani et al., 2007;
Kutsuzawa et al., 2006) and concentration (Corsi et al., 2003;
Incani et al., 2007). The toxicity of carbon nanotubes has been
recently evaluated in stem cells. There is evidence that many
factors contribute to the toxicity of carbon nanotubes, including
their concentration, size, shape, and surface coating (Magrez
et al., 2006). In a recent study, the genotoxicity of multiwalled
carbon nanotubes (MWNTs) in mESCs was reported (Zhu
et al., 2007). The results show that MWNTs accumulate and in-
duce apoptosis in mESCs and activate the tumor suppressor
protein p53 within 2 hr of exposure. A mutagenesis study using
an endogenous molecular marker, adenine phosphoribosyl-
transferase, showed that MWNTs increased the mutation fre-
quency 2-fold compared with spontaneous mutation in mESCs
(Zhu et al., 2007). The results indicate that, under the conditions
tested, carbon nanotubes are genotoxic, and further surfacechemical modification might be required before they can be
used safely in stem cell research. The mechanism responsible
for the cytotoxicity of MWNTs is unclear. Recent studies indicate
that carbon nanotubes might generate reactive oxygen species
when exposed to irradiation, and this might dramatically affect
cellular behavior (Joshi et al., 2008). It would be interesting to
study whether these reactive oxygen species are generated in
cells that accumulate MWNTs.
In addition to delivering agents into the cell to affect cell func-
tion, nanotechnologies can also be employed to create extracel-
lular microenvironments for directing stem cell function from the
outside.
Nanoscale Engineering to Create Biomimetic
Cellular Environments
In living organisms, stem cells are prevented from exiting the mi-
tototic cycle by specific environments, called niches (Scadden,
2006). These niches are formed by cellular and noncellular ele-
ments. The noncellular elements include instructive extracellular
matrix (ECM) molecules (e.g., collagen, elastin, proteoglycan,
fibronectin, and laminin) secreted by cells in the vicinity of stem
cells. These ECM molecules provide stem cells with biophysical
clues, including specific surface chemistry and topography with
nanoscale features. For example, collagen (the most abundant
ECM protein) forms triple-helical structures that pack together,
producing fibrils with a diameter ranging from 15 to 300nm (Bruns,
1976). The nanoscale structure of the ECM provides cellular an-
chorage points and presents instructive clues to guide cell behav-
ior. The ECM also creates sites for cell adhesion molecules and
the immobilization of soluble factors. Cells are in contact with
the ECM via integrins, transmembrane proteins that interact with
specific amino acid sequences found in ECM proteins. These re-
ceptors tether the cell cytoskeleton to the fibers of the ECM and
activate a cascade of intracellular signaling pathways, affecting
cellular behavior at different levels including adhesion, prolifera-
tion, migration, and differentiation (Sniadecki et al., 2006).
The ability to engineer materials to resemble the structural
complexity of ECM, including its nanotextured topography, has
made large contributions to our understanding of several cellular
processes including stem cell-matrix interactions, stem cell
differentiation in response to different nanoscale topographies,
and stem cell migration. Several patterning techniques have
been used for this purpose, as thoroughly reviewed elsewhere
(Curtis and Wilkinson, 2001; Dzenis, 2004; Geissler and Xia,
2004; Norman and Desai, 2006; Sniadecki et al., 2006).
Nanoscale Topography
Cell adhesion to the ECM causes clustering of integrins into focal
adhesion complexes and activation of intracellular signaling cas-
cades (Sniadecki et al., 2006). Focal adhesion complexes recruit
numerous proteins such as focal adhesion kinase (FAK), vinculin,
paxillin, talin, p130Cas, and others (Mitra et al., 2005). The con-
centration and topography of cell adhesion sites in the ECM are
critical for integrin clustering and activation (Figure 3). Parame-
ters including size (Park et al., 2007), lateral spacing (Park et al.,
2007), surface chemistry (Chua et al., 2006), and geometry (Dalby
et al., 2007) of the nanofeatures are important to guide stem cell
behavior. For example, adhesion, spreading, and differentiation
of rat mesenchymal stem cells into the osteogenic lineage was
highest on TiO2 nanotubes vertically aligned with a diameter of
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Substrates
Focal adhesion complexes transduce external signals from the
ECM to the cell interior. These complexes are formed by numer-
ous structural and regulatory proteins, and their composition
varies constantly depending on external cues and cellular re-
sponses (reviewed in Mitra et al., 2005). A spacing of 15 nm seems
optimal for integrin assembly into focal contacts and the induction
of assembly of actin filaments and signaling to the nucleus. Mes-
enchymal stem cells attached to these substrates have higher
adhesion, proliferation, migration, and differentiation than cells
attached to smooth surfaces (Park et al., 2007).15 nm, which roughly corresponds to the predicted lateral spac-
ing of integrin receptors in focal contacts on the extracellular
matrix, and declined significantly with increasing nanotube
diameter (Park et al., 2007). The phosphorylation of FAK and
the extracellular signal-regulated kinase (ERK), which is a target
of the FAK signaling pathway, was highest in stem cells growing
on 15 nm tubes but low on 100 nm nanotubes (Park et al., 2007).
Our research group has also shown that although the culture of
hESCs in a nanometer-scale line grating enhances the alignment
and elongation of cells and also organizes and polarizes cytoskel-
eton proteins, cell proliferation is reduced (Gerecht et al., 2007).
Furthermore, in a different study, we showed that endothelial pro-
genitor cells respond to ridge-groove grating of 1200 nm in period
and 600 nm in depth with alignment, elongation, reduced prolifer-
ation, and enhanced migration (Bettinger et al., 2008). Although
endothelial cell-specific markers were not significantly altered,
endothelial progenitor cells cultured on substrate nanotopogra-
phy formed supercellular band structures after 6 days (Bettinger
et al., 2008).
The simultaneous effect of surface topography with surface
chemistry has been evaluated in the context of stem cell differen-
tiation. Compared to flat substrates, substrates with nanoscale
features and different chemistries (silica [Lipski et al., 2007], alu-
mina [Popat et al., 2007], and poly[methyl methacrylate] [Dalby
et al., 2006]) have been reported to enhance the adhesion,
growth, and osteogenic differentiation of hMSCs (Lipski et al.,
2007) and marrow stromal cells (Dalby et al., 2006; Popat
et al., 2007), and could have potential application as osteogenic
coatings for orthopedic implants. Moreover, the combination of
substrate topography with substrate electrical conductivity has
been shown to contribute to the differentiation of NSCs into
specific neuronal lineages (Jan and Kotov, 2007).
In addition to the dimensions of nanotopographical features,
their conformation (e.g., ridges, grooves, whorls, pits, and pores)
and symmetry may be equally important. Surfaces with different
levels of nanoscale order and symmetry have been created to
stimulate the in vivo differentiation of osteogenic progenitor cells
(Dalby et al., 2007). Strikingly, the disordered nanoscale features
stimulated hMSCs to produce bone mineral in vitro, in the
absence of osteogenic supplements at levels similar to stem
cells grown on flat surfaces and exposed to osteogenic supple-
ments. These nanofeatures might be incorporated into orthope-
dic repair material to influence osteogenic progenitor cells in vivo
to produce mature osteoblasts leading to direct bone-material
contact, rather than fibrous tissue, one of the problems associ-
ated with orthopedic biomaterials.
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properties and differentiation potentials, they will likely respond
differently to nanoscale features. Unfortunately, the current lack
of systematic studies assessing the effect of nanoscale features
on multiple types of stem cells under the same conditions
prevents any inferences or conclusions. Furthermore, the general
mechanism underlying cellular response to nanofeatures re-
mains undefined. The alteration of cellular function at nanostruc-
tured interfaces may result from (1) direct influence on cellular
responses or (2) an altered extracellular layer matrix deposited
on the surface and consequent change in the availability of bind-
ing sites. When cells adhere to a material, they interact not with
the material itself but with proteins adsorbed to the material (Wil-
son et al., 2005). The mechanisms underlying the influence of
nanostructured surfaces on cellular response likely involve the
organization of integrins in the cellular membrane, which in turn
can modify cytoskeleton organization and intracellular signaling
mediated by FAK, vinculin, paxillin, and other proteins (Mitra
et al., 2005). In some cases, stem cells grown on nanotextured
surfaces are elongated, with a stretched nuclear morphology
that might alter the internal nuclear matrix structure and hence
affect the expression of silent genes (Dang and Leong, 2007).
Nanofiber-Assembly Scaffolds
The regenerative potential of stem cells has been demonstrated
in vivo by injecting cells suspended in an appropriate medium
into the desired tissue. However, this approach limits the spread
of the cells from the injection site, and in some cases, the in-
jected cells have poor engraftment. Specifically, one of the
greatest challenges in traditional stem cell therapies involving di-
rect injection of cells into local tissues is that fewer than 10% of
cells engraft (Laflamme and Murry, 2005; Mooney and Vanden-
burgh, 2008). This likely results from a combination of different
factors, including the loss of cells from the injection site into
the circulation or other tissues, cell death due to the absence
of an appropriate ECM for cell adhesion, and lack of efficient
mass transport of oxygen and nutrients to the transplanted cells.
Stem cell transplantation efficiency might be enhanced by plac-
ing the cells in biocompatible and biodegradable scaffolds that
act as a temporary three-dimensional ECM for cell adhesion,
survival, migration, differentiation, and organization. Specifically,
scaffolds can be designed to prevent anoikis of the transplanted
cells, improve cell survival and promote migration, guide stem
cell differentiation and three-dimensional organization, and
promote adequate responses from the host tissue for the sur-
vival of the cells (e.g., promoting the vascularization of the tissue
constructs) (Mooney and Vandenburgh, 2008).
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fibrous network of ECM and to improve stem cell transplantation
(Figure 4). Nanofiber-based scaffolds have high porosity and
specific surface area and present nanometer-scale topographi-
cal cues that are potent effectors of cellular behavior (see above).
Nanofibers with controlled diameter have been prepared by
electrospinning (Dzenis, 2004; Murugan and Ramakrishna,
2007; Norman and Desai, 2006) or by self-assembly of peptide
amphiphile molecules (Silva et al., 2004). Synthetic polymers
such as poly(lactic acid) (PLA), poly(caprolactone), poly(amide),
or natural polymers including collagen, silk protein, and chitosan
have been electrospun into nanofibers. The electrospun fibers
can be aligned by manipulating the electrical field or by collecting
the fibers on a rotating target, producing three-dimensional
scaffolds.
Typically, stem cells cultured on nanofiber scaffolds differ in
morphology, viability, and migration from cells cultured on con-
ventional substrates. For example, hMSCs grown on 500–
1,000 nm nanofibers are flatter and demonstrate significantly
higher cell viability and lower cell mobility than control cells
grown on tissue culture polystyrene (Shih et al., 2006). Clearly
nanofiber scaffolds offer great potential for stem cell applica-
tions, yet systematic studies are needed to define how specific
scaffold properties affect cell function prior to creating ‘‘de-
signer’’ scaffolds for particular applications.
One of the potential applications of nanofiber-based scaffolds
is in the creation of synthetic niches for stem cell self-renewal.
The chemical, mechanical, and three-dimensional features of
these scaffolds can influence the activation of different signaling
pathways, resulting in stem cell proliferation and self-renewal
(Nur et al., 2006). Another application of these scaffolds is for
stem cell differentiation. Studies have shown that the differenti-
ation process correlates with the amplification of bioactive
Figure 4. Nanofiber-Assembly Scaffolds for Tissue
Engineering
Initially, stem cells or progenitor cells are seeded on three-di-
mensional scaffolds formed by nanofibers. These nanofibers
may present a high density of ligands, including cell-adhesion
epitopes or immobilized growth factors, for stem cell differen-
tiation. The tissue constructs can be implanted immediately
after incorporation of a cell source (<24 hr) into the defective
tissue. Alternatively, the tissue constructs can be cultured in
bioreactors to allow cell proliferation, differentiation, and
three-dimensional organization before their final implantation.
In both cases, the scaffold acts as a temporary 3D ECM for cell
adhesion and tissue formation and typically is designed to
degrade when new extracellular matrix is deposited.
epitope presentation to cells by the nanofibers
(Silva et al., 2004). The high density of epitopes
on nanofibers is a direct consequence of their
high surface area and tailored chemistry and can
be several orders higher than the density of epi-
topes in substrates formed by ECM components
like laminin (Silva et al., 2004). The nanofibers in
the scaffold can be aligned to create complex guid-
ance channels for the alignment of stem cells or
progenitor cells (Yang et al., 2005). Cell alignment
in tissue constructs might be particularly important
for the treatment of nerve tissue after spinal cord injury and the
regeneration of cardiac and muscle tissues.
Cells are generally seeded on top of the nanofiber-based
scaffolds to repopulate the matrix. The small pore size of these
scaffolds might prevent cell invasion into the interior of the
matrix and, thus, the formation of a homogenous tissue con-
struct (Li et al., 2008). Therefore, unless these nanofiber-based
scaffolds are engineered to have enzyme-degradable links that
can be rapidly degraded by advancing cells, they might provide
more suitable substrates for the development of cell sheets that
can subsequently be assembled to form tissues. In a recent
study, scaffolds composed of thermally responsive hydroxy-
butyl chitosan nanofibers (diameter of 436 nm) were used to
produce aligned cell sheets derived from hMSCs (Dang and
Leong, 2007). hMSCs cultured on the surface of chitosan nano-
fiber scaffolds showed alignment and elongation in both cell
body and nucleus and underwent myogenic differentiation.
The thermal dissolution of the fiber-based scaffold produced
aligned cell sheets that might be used in engineering of tissue
constructs for cardiac and muscle regeneration (Dang and
Leong, 2007).
One of the ultimate applications of nanofiber-based scaffolds
is in vivo stem cell transplantation. In this case the scaffold would
act as a temporary ECM to guide tissue formation and typically
would degrade in concert with deposition of new ECM. Unfortu-
nately, there are few in vivo studies of stem cells transplanted
into these scaffolds (Hashi et al., 2007). In contrast to traditional
scaffolds for cell transplantation, nanofiber-based scaffolds of-
fer the opportunity to control stem cell behavior by incorporation
of high-density epitopes and control of cell alignment. Moreover,
the intrinsic properties of the scaffolds might contribute to the
differentiation of endogenous stem cells in the vicinity of the
implant.
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Currently, there are 2,045 clinical trials involving stem cells (www.
clinicaltrials.gov, accessed March 24, 2008). For clinical efficacy,
it is imperative to image stem cells and their final location in vivo.
Detection by MRI of magnetic nanoparticle-labeled stem cells
may serve as a suitable means to achieve this objective; however,
clinical studies are needed. The gradual loss of MRI cell signal
due to cell division should be addressed in future studies. Qdots
might be an alternative for the long-term labeling of stem cells.
However, the current cost of qdot labeling and accessibility of
whole animal imaging is a barrier to large-scale studies; hopefully,
this issue will be overcome soon. In the mean time, we believe that
qdots will be particularly useful for ex vivo assays. Qdots offer
a unique platform to study the dynamics of biomolecules and
intracellular compartments in stem cells. Further studies will be
required to demonstrate the effect of qdots on stem cell self-
renewal and differentiation, particularly in embryonic stem cells.
Many powerful strategies for the differentiation of stem cells
require the delivery of biomolecules into the cytosolic or nuclear
compartments. In most cases, it is largely unknown how vectors
are internalized by stem cells, information likely to be critical for
the design of more efficient delivery systems. Carbon nanotubes
that cross the cell membrane through mechanisms other than
endocytosis might be an interesting approach to deliver biomol-
ecules within stem cells (Kostarelos et al., 2007); however,
further studies are needed to study cytotoxicity and effects on
stem cell differentiation.
The successful in vivo engraftment of stem cells might require
the use of biomaterials in the form of scaffolds, which would
isolate the cells at the transplantation site and act as a temporary
three-dimensional ECM to guide tissue formation. These scaf-
folds can incorporate nanocarriers to deliver biomolecules at spe-
cific times and places within the network, and the migration and
differentiation of stem cells can be tracked by the imaging tools
described above. Specifically, nanofiber-assembly scaffolds
might improve stem cell differentiation and in vivo engraftment.
The combined effect of nanofiber organization and immobilized
bioactive factors will likely contribute to cell guidance and differ-
entiation in vivo. Moreover, it is clear that surface nanotopography
can influence stem cell adhesion, migration,differentiation, matrix
production, and autocrine and paracrine signaling events. Ap-
proaches to incorporate nanotextures on implant or scaffold sur-
faces may be useful to guide tissue regeneration through direct
influence on exogenous or endogenous stem or progenitor cells.
Nanotechnologies clearly have great potential to enhance stem
cell research and stem cell-based therapeutics. They have al-
ready begun to advance our ability to understand and control
stem cell-fate decisions and to engineer novel stem cell technolo-
gies, with the ultimate goal to create stem cell-based therapeutics
for the prevention, diagnosis, and treatment of human diseases.
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